Patently-O

Method or Molecule: Judge Dyk Dissents from En Banc Denial in Teva v. Lilly

Federal Circuit denies en banc review in Teva v. Lilly over Judge Dyk's dissent, leaving method claims to an antibody genus intact after Amgen. Continue reading this post on Patently-O.

作者 Patently-O

1 分钟阅读
Method or Molecule: Judge Dyk Dissents from En Banc Denial in Teva v. Lilly
Method or Molecule: Judge Dyk Dissents from En Banc Denial in Teva v. Lilly

有活动行业的新闻要分享吗?

提交新闻稿或信息,触达数千名活动行业专业人士。

联系我们→

更多Intellectual Property Law相关内容

相关洞察